Terms ending in 2029
Every in-force patent on Ambrx, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,736,872 | Compositions of Aminoacyl-Trna Synthetase and Uses Thereof In force · High confidence | Ambrx, Inc. | In force | High confidence | |
| US 8,263,740 | Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acids and Polypeptides In force · High confidence | Ambrx, Inc. | In force | High confidence | |
| US 9,133,495 | Hybrid Suppressor Trna for Vertebrate Cells In force · High confidence | Ambrx, Inc. | In force | High confidence | |
| US 11,542,310 | Modified Bovine G-CSF Polypeptides And Their Uses In force · High confidence | Elanco US Inc. | In force | High confidence | |
| US 12,612,440 | Modified Bovine G-Csf Polypeptides and Their Uses In force · Medium confidence | Ambrx, Inc. | In force | Medium confidence | |
| US 8,420,792 | Suppressor Trna Transcription in Vertebrate Cells In force · High confidence | Ambrx, Inc. | In force | High confidence | |
| US 9,121,025 | Non-Natural Amino Acid Replication-Dependent Microorganisms and Vaccines In force · Medium confidence | Ambrx, Inc. | In force | Medium confidence | |
| US 10,428,333 | Non-Natural Amino Acid Replication-Dependent Microorganisms and Vaccines In force · Medium confidence | Ambrx, Inc. | In force | Medium confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
7 of these are in force and held by Ambrx, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.